These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29769578)

  • 1. Metabolomic profile of systemic sclerosis patients.
    Murgia F; Svegliati S; Poddighe S; Lussu M; Manzin A; Spadoni T; Fischetti C; Gabrielli A; Atzori L
    Sci Rep; 2018 May; 8(1):7626. PubMed ID: 29769578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Earliest Phase of Systemic Sclerosis Typified by Increased Levels of Inflammatory Proteins in the Serum.
    Cossu M; van Bon L; Preti C; Rossato M; Beretta L; Radstake TRDJ
    Arthritis Rheumatol; 2017 Dec; 69(12):2359-2369. PubMed ID: 28859262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis.
    Corrado A; Colia R; Mele A; Di Bello V; Trotta A; Neve A; Cantatore FP
    PLoS One; 2015; 10(9):e0137912. PubMed ID: 26375284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of galectin-3: possible association with fibrosis, aberrant angiogenesis, and immune activation in patients with systemic sclerosis.
    Taniguchi T; Asano Y; Akamata K; Noda S; Masui Y; Yamada D; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
    J Rheumatol; 2012 Mar; 39(3):539-44. PubMed ID: 22247367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spleen elastography in patients with Systemic sclerosis.
    Karalilova R; Doykova K; Batalov Z; Doykov D; Batalov A
    Rheumatol Int; 2021 Mar; 41(3):633-641. PubMed ID: 33495915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum metabolomic profiling reveals potential biomarkers in systemic sclerosis.
    Guo M; Liu D; Jiang Y; Chen W; Zhao L; Bao D; Li Y; Distler JHW; Zhu H
    Metabolism; 2023 Jul; 144():155587. PubMed ID: 37156409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum concentration of surfactant protein D in patients with systemic sclerosis: The potential marker of the interstitial lung disease severity.
    Grosicka A; Manasar A; Kucharz EJ; Kotyla PJ
    Best Pract Res Clin Rheumatol; 2018 Aug; 32(4):541-549. PubMed ID: 31174823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.
    Almeida I; Silva SV; Fonseca AR; Silva I; Vasconcelos C; Lima M
    Clin Rev Allergy Immunol; 2015 Dec; 49(3):347-69. PubMed ID: 26445774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis.
    Noda S; Asano Y; Takahashi T; Akamata K; Aozasa N; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
    Rheumatology (Oxford); 2013 May; 52(5):790-9. PubMed ID: 23287360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis.
    Wohlfahrt T; Usherenko S; Englbrecht M; Dees C; Weber S; Beyer C; Gelse K; Distler O; Schett G; Distler JH; Ramming A
    Ann Rheum Dis; 2016 Mar; 75(3):623-6. PubMed ID: 26338035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum metabolite differences detected by HILIC UHPLC-Q-TOF MS in systemic sclerosis.
    Sun C; Zhu H; Wang Y; Han Y; Zhang D; Cao X; Alip M; Nie M; Xu X; Lv L; Feng X; Sun L; Wang D
    Clin Rheumatol; 2023 Jan; 42(1):125-134. PubMed ID: 36127550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
    Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
    J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief report: lysyl oxidase is a potential biomarker of fibrosis in systemic sclerosis.
    Rimar D; Rosner I; Nov Y; Slobodin G; Rozenbaum M; Halasz K; Haj T; Jiries N; Kaly L; Boulman N; Daood R; Vadasz Z
    Arthritis Rheumatol; 2014 Mar; 66(3):726-30. PubMed ID: 24574233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of combined anti-CCP antibodies and rheumatoid factor in a New Zealand cohort of patients with systemic sclerosis.
    Kamalaksha S; White DHN; Solanki KK
    Int J Rheum Dis; 2018 Jul; 21(7):1430-1435. PubMed ID: 29968328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of serum retinol binding protein-4 levels in patients with systemic sclerosis.
    Toyama T; Asano Y; Takahashi T; Aozasa N; Akamata K; Noda S; Taniguchi T; Ichimura Y; Sumida H; Tamaki Z; Masui Y; Tada Y; Sugaya M; Sato S; Kadono T
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):337-44. PubMed ID: 22211766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Serum Levels of the IL-33 Neutralizing sST2 in Limited Cutaneous Systemic Sclerosis.
    Wagner A; Köhm M; Nordin A; Svenungsson E; Pfeilschifter JM; Radeke HH
    Scand J Immunol; 2015 Sep; 82(3):269-74. PubMed ID: 26095613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
    Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V;
    Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum protein levels of YKL-40 and plasma miR-214 expression in patients with systemic sclerosis.
    Dichev V; Mehterov NH; Kazakova MH; Karalilova RV; Batalov AZ; Sarafian VS
    Mod Rheumatol; 2021 Sep; 31(5):1010-1018. PubMed ID: 33274678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical differences between Thai systemic sclerosis patients with positive versus negative anti-topoisomerase I.
    Foocharoen C; Suwannachat P; Netwijitpan S; Mahakkanukrauh A; Suwannaroj S; Nanagara R;
    Int J Rheum Dis; 2016 Mar; 19(3):312-20. PubMed ID: 25293362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.